249 related articles for article (PubMed ID: 23329849)
1. Impact of antiretroviral therapy duration and intensification on isolated shedding of HIV-1 RNA in semen.
Osborne BJ; Sheth PM; Yi TJ; Kovacs C; Benko E; Porte Cl; Huibner S; Le AQ; Danroth R; Baraki B; Mazzulli T; Brumme ZL; Kaul R
J Infect Dis; 2013 Apr; 207(8):1226-34. PubMed ID: 23329849
[TBL] [Abstract][Full Text] [Related]
2. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy.
Sheth PM; Kovacs C; Kemal KS; Jones RB; Raboud JM; Pilon R; la Porte C; Ostrowski M; Loutfy M; Burger H; Weiser B; Kaul R;
AIDS; 2009 Sep; 23(15):2050-4. PubMed ID: 19710596
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.
Zhang H; Dornadula G; Beumont M; Livornese L; Van Uitert B; Henning K; Pomerantz RJ
N Engl J Med; 1998 Dec; 339(25):1803-9. PubMed ID: 9854115
[TBL] [Abstract][Full Text] [Related]
4. Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.
Chaillon A; Gianella S; Lada SM; Perez-Santiago J; Jordan P; Ignacio C; Karris M; Richman DD; Mehta SR; Little SJ; Wertheim JO; Smith DM
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142136
[TBL] [Abstract][Full Text] [Related]
5. Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection.
Puertas MC; Massanella M; Llibre JM; Ballestero M; Buzon MJ; Ouchi D; Esteve A; Boix J; Manzardo C; Miró JM; Gatell JM; Clotet B; Blanco J; Martinez-Picado J;
AIDS; 2014 Jan; 28(3):325-34. PubMed ID: 24185044
[TBL] [Abstract][Full Text] [Related]
6. Antiviral effect of maraviroc in semen: a case report.
Pasquier C; Moinard N; Sauné K; Daudin M; Trancart S; Massip P; Izopet J; Bujan L
Antivir Ther; 2012; 17(5):933-6. PubMed ID: 22297568
[TBL] [Abstract][Full Text] [Related]
7. Long-term suppressive combined antiretroviral treatment does not normalize the serum level of soluble CD14.
Méndez-Lagares G; Romero-Sánchez MC; Ruiz-Mateos E; Genebat M; Ferrando-Martínez S; Muñoz-Fernández MÁ; Pacheco YM; Leal M
J Infect Dis; 2013 Apr; 207(8):1221-5. PubMed ID: 23322858
[TBL] [Abstract][Full Text] [Related]
8. Monitoring the emergence of resistance mutations in patients infected with HIV-1 under salvage therapy with raltegravir in Rio de Janeiro, Brazil: a follow-up study.
Passaes CP; Guimarães ML; Cardoso SW; Pilotto JH; Veloso V; Grinsztejn B; Morgado MG
J Med Virol; 2012 Dec; 84(12):1869-75. PubMed ID: 23080489
[TBL] [Abstract][Full Text] [Related]
9. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma.
Marcelin AG; Tubiana R; Lambert-Niclot S; Lefebvre G; Dominguez S; Bonmarchand M; Vauthier-Brouzes D; Marguet F; Mousset-Simeon N; Peytavin G; Poirot C
AIDS; 2008 Aug; 22(13):1677-9. PubMed ID: 18670231
[TBL] [Abstract][Full Text] [Related]
10. Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA.
Gianella S; von Wyl V; Fischer M; Niederoest B; Battegay M; Bernasconi E; Cavassini M; Rauch A; Hirschel B; Vernazza P; Weber R; Joos B; Günthard HF;
Antivir Ther; 2011; 16(4):535-45. PubMed ID: 21685541
[TBL] [Abstract][Full Text] [Related]
11. Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract.
Pasquier CJ; Moinard N; Sauné K; Souyris C; Lavit M; Daudin M; Izopet J; Bujan L
AIDS; 2008 Sep; 22(14):1894-6. PubMed ID: 18753873
[No Abstract] [Full Text] [Related]
12. Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study.
Llibre JM; Buzón MJ; Massanella M; Esteve A; Dahl V; Puertas MC; Domingo P; Gatell JM; Larrouse M; Gutierrez M; Palmer S; Stevenson M; Blanco J; Martinez-Picado J; Clotet B
Antivir Ther; 2012; 17(2):355-64. PubMed ID: 22290239
[TBL] [Abstract][Full Text] [Related]
13. Seminal HIV-1 RNA Detection in Heterosexual African Men Initiating Antiretroviral Therapy.
Mujugira A; Coombs RW; Heffron R; Celum C; Ronald A; Mugo N; Baeten JM;
J Infect Dis; 2016 Jul; 214(2):212-5. PubMed ID: 27053765
[TBL] [Abstract][Full Text] [Related]
14. Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration.
Baroncelli S; Villani P; Weimer LE; Ladisa N; Francisci D; Tommasi C; Vullo V; Preziosi R; Cicalini S; Cusato M; Galluzzo C; Floridia M; Regazzi M;
Ann Pharmacother; 2010 May; 44(5):838-43. PubMed ID: 20371753
[TBL] [Abstract][Full Text] [Related]
15. Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine.
Ghosn J; Chaix ML; Peytavin G; Bresson JL; Galimand J; Girard PM; Raffi F; Cohen-Codar I; Delfraissy JF; Rouzioux C
J Antimicrob Chemother; 2008 Jun; 61(6):1344-7. PubMed ID: 18343806
[TBL] [Abstract][Full Text] [Related]
16. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma on a 2002-2011 survey.
Lambert-Niclot S; Tubiana R; Beaudoux C; Lefebvre G; Caby F; Bonmarchand M; Naouri M; Schubert B; Dommergues M; Calvez V; Flandre P; Poirot C; Marcelin AG
AIDS; 2012 May; 26(8):971-5. PubMed ID: 22382146
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens.
Ghosn J; Leruez-Ville M; Blanche J; Delobelle A; Beaudoux C; Mascard L; Lecuyer H; Canestri A; Landman R; Zucman D; Ponscarme D; Rami A; Viard JP; Spire B; Rouzioux C; Costagliola D; Suzan-Monti M;
Clin Infect Dis; 2014 Jun; 58(12):1763-70. PubMed ID: 24647014
[TBL] [Abstract][Full Text] [Related]
18. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.
Cillo AR; Hilldorfer BB; Lalama CM; McKinnon JE; Coombs RW; Tenorio AR; Fox L; Gandhi RT; Ribaudo H; Currier JS; Gulick RM; Wilkin TJ; Mellors JW
AIDS; 2015 Oct; 29(16):2121-9. PubMed ID: 26544577
[TBL] [Abstract][Full Text] [Related]
19. Mucosal correlates of isolated HIV semen shedding during effective antiretroviral therapy.
Sheth PM; Yi TJ; Kovacs C; Kemal KS; Jones RB; Osborne B; Pilon R; la Porte C; Ostrowski M; Mazzulli T; Burger H; Weiser B; Kaul R
Mucosal Immunol; 2012 May; 5(3):248-57. PubMed ID: 22318494
[TBL] [Abstract][Full Text] [Related]
20. HIV-1-RNA in seminal plasma correlates with detection of HIV-1-DNA in semen cells, but not with CMV shedding, among MSM on successful antiretroviral regimens.
Gantner P; Assoumou L; Leruez-Ville M; David L; Suzan-Monti M; Costagliola D; Rouzioux C; Ghosn J;
J Antimicrob Chemother; 2016 Nov; 71(11):3202-3205. PubMed ID: 27432601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
